Lack of Attention to the Administration of Fampridine as a Symptomatic Drug in Iranian Multiple Sclerosis Patients Abdorreza Naser Moghadasi Multiple Sclerosis Research Center, Neuroscience Institute, Tehran University of Medical Sciences, Tehran, Iran DOI: https://doi.org/10.18502/ijph.v50i7.6654 Abstract The article’s abstract is not available. PDF Published 2021-07-05 Issue Volume (50) issue (7) Section Articles
